FARO 250117 22.50C (FARO250117C22500) Stock Options, News & Quotes

US OptionsDetailed Quotes

FARO250117C22500

Watchlist

7.10
0.000.00%

15min DelayClose Dec 24 13:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Shareholders in FARO Technologies (NASDAQ:FARO) Have Lost 64%, as Stock Drops 9.5% This Past Week
Simply Wall StDec 24 06:50 ET
Faro Technologies Analyst Ratings
BenzingaDec 12 11:20 ET · Ratings
Craig-Hallum Maintains Faro Technologies(FARO.US) With Buy Rating, Announces Target Price $33
Moomoo NewsDec 12 09:31 ET · Ratings
Express News | Faro Technologies Inc : Craig-Hallum Raises Target Price to $33 From $30
ReutersDec 12 07:37 ET
Analysts Offer Insights on Technology Companies: Sprinklr (CXM), Ciena (CIEN) and Faro Technologies (FARO)
TipRanksDec 5 13:10 ET · Ratings
Craig-Hallum Maintains Faro Technologies(FARO.US) With Buy Rating
Moomoo NewsDec 5 12:31 ET · Ratings

Comments

Moomoo AI

Jan 16 15:10

CEO Peter Lau expresses confidence in Horwath's understanding of FARO and his execution abilities, making him the ideal CFO. Horwath is eager for the opportunity and anticipates collaborating with Lau to expand the business.

Press Release: FARO Technologies Announces CFO Transition

Moomoo AI

Dec 20, 2023 06:44

FARO Technologies manages a reasonable debt load due to its net cash position, but its slow growth rate, negative free cash flow and lack of profitability bring skepticism about its future prospects.

FARO Technologies (NASDAQ:FARO) Has Debt But No Earnings; Should You Worry?

Greenback Stocks

Jun 15, 2023 16:23

$Faro Technologies (FARO.US)$ watch

Moomoo Breakfast US

Jun 3, 2022 07:29

Columns Today's pre-market stock movers: TSLA, CHGG, OKTA, TPTX and more

Gainers:
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...